US Stock MarketDetailed Quotes

LBPH Longboard Pharmaceuticals

Watchlist
  • 59.800
  • +0.030+0.05%
Close Nov 22 16:00 ET
  • 59.800
  • 0.0000.00%
Post 20:01 ET
2.33BMarket Cap-26577P/E (TTM)

Longboard Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Longboard Pharmaceuticals Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 4 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 0.000--
--2024/Q4-- / 0.000--
--2024/Q30.000 / 0.000--
Aug 1, 20242024/Q20.000 / 0.000--
--2024/Q10.000 / 0.000--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 0.000--
--2024/Q4-- / 0.000--
--2024/Q30.000 / 0.000--
Aug 1, 20242024/Q20.000 / 0.000--
--2024/Q10.000 / 0.000--

Unlock Free Earnings Estimates

Longboard Pharmaceuticals Earnings Reports

  • Longboard Pharmaceuticals | 10-Q: Q3 2024 Earnings Report

    Nov 7 16:19 ET

  • Longboard Pharmaceuticals | 8-K: Longboard Pharmaceuticals Reports Third Quarter 2024 Financial Results and Provides Corporate Updates

    Nov 7 16:08 ET

  • Longboard Pharmaceuticals | 10-Q: Q2 2024 Earnings Report

    Aug 1 16:25 ET

  • Longboard Pharmaceuticals | 8-K: Longboard Pharmaceuticals Reports Second Quarter 2024 Financial Results and Provides Corporate Updates

    Aug 1 16:12 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Nov 23, 2024

    Hold

    • Buy

      16.67%

    • Hold

      83.33%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    % Chg

    No Data